Dr. Jorge Luis Sifre, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 83 Calle Roble, Ciudad Jardin Iii, Toa Alta, PR 00953 Phone: 787-637-8215 |
Daliza Molina Cuevas, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: C-1 Jardines De Toa Alta, Lote 7 A, Toa Alta, PR 00953 Phone: 787-870-5922 Fax: 787-870-5922 |
Dr. Odrick Roberto Rosas, M.D., PH.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Calle 1, A1 Urb San Fernando, Toa Alta, PR 00954 Phone: 787-870-8403 |
News Archive
Participants in clinical trials report being satisfied with personalized, accurate communication of results by study investigators soon after the study findings are released publicly, according to a report in the December issue of Archives of Neurology.
AbbVie, a global biopharmaceutical company, today announced that a Phase 2 trial of its investigational medicine venetoclax met its primary endpoint of achieving overall response rates in patients with relapsed/refractory or previously untreated chronic lymphocytic leukemia (CLL) with 17p deletion, according to an independent review analysis.
One of the most distinctive signs of the development of Alzheimer's disease is a change in the behavior of a protein that neuroscientists call tau. In normal brains, tau is present in individual units essential to neuron health. In the cells of Alzheimer's brains, by contrast, tau proteins aggregate into twisted structures known as "neurofibrillary tangles."
The Rare Disease Cures Accelerator-Data and Analytics Platform initiative officially launched its next phase on Tuesday establishing itself as the leading platform to accelerate rare disease treatment innovation.
A two-year, $12 million contract with the U.S. Department of Defense Office of Technology Transition (OTT) will jumpstart human trials of three innovative research programs that aim to replace scars and defects with healthy, functional tissues, announced officials of the University of Pittsburgh and the McGowan Institute for Regenerative Medicine today at the Institute's Second Annual Open Session, Soldiers and Sailors Memorial Hall, Oakland.
› Verified 2 days ago